Top

Published in:

Open Access 01-12-2017 | Research article

Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery

Authors: Sebastian T. Lugg, Theofano Tikka, Paula J. Agostini, Amy Kerr, Kerry Adams, Maninder S. Kalkat, Richard S. Steyn, Pala B. Rajesh, Ehab Bishay, David R. Thickett, Babu Naidu

Published in: Journal of Cardiothoracic Surgery | Issue 1/2017

Abstract

Background

Smoking is a risk factor for postoperative pulmonary complications (PPC) following non-small cell lung cancer (NSCLC) surgery. The optimal timing for preoperative smoking cessation has not been identified. Our study aimed to observe the impact of preoperative smoking cessation on PPC incidence and other postoperative outcomes including long-term survival.

Methods

A prospective study included consecutive patients following resection for NSCLC in a regional thoracic centre over a 4-year period (2010–2014). Patients were stratified according to self-reported preoperative smoking status. The primary endpoint was PPC incidence, which was assessed from postoperative day one onwards using the Melbourne Group Scale. Secondary endpoints included short-term outcomes (hospital length of stay [LOS], intensive therapy unit [ITU] admission, 30-day hospital readmission rate) and long-term survival.

Results

Four hundred and sixty-two patients included 111 (24%) current smokers, 55 (12%) ex-smokers <6 weeks, 245 (53%) ex-smokers ≥6 weeks and 51 (11%) never smokers. PPC occurred in 60 (13%) patients in total. Compared to never smokers, current smokers had a higher frequency of PPC (22% vs. 2%, p = 0.004), higher frequency of ITU admission (14% vs. 0%; p = 0.001) and a longer median (IQR) hospital LOS (6 [5] vs. 5 [2]; p = 0.001). In the ex-smokers there was a trend for a lower frequency of PPC (<6 weeks, 10.9% vs. ≥6 weeks, 11.8%) and ITU admission (<6 weeks, 5.5% vs. ≥6 weeks, 4.5%), but there was no difference between the <6 weeks or ≥6 weeks ex-smoking groups prior to surgery. There was no significant difference in long-term survival found between the groups of differing smoking status (median follow-up 29.8 months, 95%CI 28.4–31.1).

Conclusion

Current smokers have higher postoperative morbidity; this risk reduces following smoking cessation but 6 weeks does not appear to identify a time-point where differences in outcomes are noted.

Agostini P, Cieslik H, Rathinam S, Bishay E, Kalkat MS, Rajesh PB, et al. Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors? Thorax. 2010;65:815–8.CrossRefPubMed

Lugg ST, Agostini PJ, Tikka T, Kerr A, Adams K, Bishay E, et al. Long-term impact of developing a postoperative pulmonary complication after lung surgery. Thorax. 2016;71:171–6.CrossRefPubMed

Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. The prognostic impact of cigarette smoking on patients with non-small cell lung cancer. J Thorac Oncol. 2011;6:735–42.CrossRefPubMed

Nakagawa M, Tanaka H, Tsukuma H, Kishi Y. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest. 2001;120:705–10.CrossRefPubMed

Mason DP, Subramanian S, Nowicki ER, Grab JD, Murthy SC, Rice TW, et al. Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg. 2009;88:362–70.CrossRefPubMed

Lim E, Baldwin D, Beckles M, Duffy J, Entwisle J, Faivre-Finn C, et al. Guidelines on the radical management of patients with lung cancer. Thorax. 2010;65(Suppl 3:iii):1–27.

Thomsen T, Villebro N, Møller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2010;7:CD002294.

Zaman M, Bilal H, Mahmood S, Tang A. Does getting smokers to stop smoking before lung resections reduce their risk? Interact Cardiovasc Thorac Surg. 2012;14:320–3.CrossRefPubMed

Sawabata N, Miyoshi S, Matsumura A, Ohta M, Maeda H, Sueki H, et al. Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma. Gen Thorac Cardiovasc Surg. 2007;55:420–4.CrossRefPubMed

10.

Barrera R, Shi W, Amar D, Thaler HT, Gabovich N, Bains MS, et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest. 2005;127:1977–83.CrossRefPubMed

11.

Groth SS, Whitson BA, Kuskowski MA, Holmstrom AM, Rubins JB, Kelly RF. Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for non-small cell lung cancer. Lung Cancer. 2009;64:352–7.CrossRefPubMed

12.

Seok Y, Hong N, Lee E. Impact of smoking history on postoperative pulmonary complications: a review of recent lung cancer patients. Ann Thorac Cardiovasc Surg. 2014;20:123–8.CrossRefPubMed

13.

West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for the common standard. Addiction. 2005;100:299–303.CrossRefPubMed

14.

Dobson Amato KA, Hyland A, Reed R, Mahoney MC, Marshall J, Giovino G, et al. Tobacco cessation may improve lung cancer patient survival. J Thorac Oncol. 2015;10:1014–19.CrossRefPubMedPubMedCentral

15.

Mungo B, Zogg CK, Hooker CM, Yang SC, Battafarano RJ, Brock MV, et al. Does obesity affect the outcome of pulmonary resections for lung cancer? A National Surgical Quality Improvement Program analysis. Surgery. 2015;157:792–800.CrossRefPubMed

16.

Ramos EM, De Toledo AC, Xavier RF, et al. Reversibility of impaired nasal mucociliary clearance in smokers following a smoking cessation programme. Respirology. 2011;16:849–55.CrossRefPubMed

17.

Martin RR. Cigarette smoking and pulmonary macrophages. Hosp Prac. 1977;12:97–104.CrossRef

18.

King Jr TE, Savici D, Campbell PA. Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis. 1988;158:1309–16.CrossRefPubMed

19.

McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med. 1994;150:696–703.CrossRefPubMed

20.

Kotani N, Hashimoto H, Sessler DI, Yoshida H, Kimura N, Okawa H, et al. Smoking decreases alveolar macrophage function during anesthesia and surgery. Anesthesiology. 2000;92:1268–77.CrossRefPubMed

21.

Bradley A, Marshall A, Stonehewer L, Reaper L, Parker K, Bevan-Smith E, et al. Pulmonary rehabilitation programme for patients undergoing curative lung cancer surgery. Eur J Cardiothorac Surg. 2013;44:266–71.CrossRef

22.

Thomsen T, Villebro N, Møller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2014;3:CD002294.

23.

Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: A randomised clinical trial. Lancet. 2002;359:114–7.CrossRefPubMed

24.

Sorensen LT, Jorgensen T. Short-term preoperative smoking cessation intervention does not affect postoperative complications in colorectal surgery: A randomised clinical trial. Colorectal Dis. 2003;5:347–52.CrossRefPubMed

25.

Jiménez-Ruiz CA, Andreas S, Lewis KE, Tonnesen P, van Schayck CP, Hajek P, et al. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J. 2015;46:61–79.CrossRefPubMed

26.

Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009;11:12–24.CrossRefPubMed

27.

Ceppa DP, Kosinski AS, Berry MF, Tong BC, Harpole DH, Mitchell JD, et al. Thorascopic lobectomy has increasing benefit in patients with poor pulmonary function : a Society of Thoracic Surgeons Database analysis. Ann Surg. 2012;256:487–93.CrossRefPubMedPubMedCentral

28.

Boffa DJ, Dhamija A, Kosinski AS, Kim AW, Detterbeck FC, Mitchell JD, et al. Fewer complications result from a video-assisted approach to anatomic resection of clinical stage I lung cancer. J Thorac Cardiovasc Surg. 2014;148:637–43.CrossRefPubMed

Title: Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery
Authors: Sebastian T. Lugg
Theofano Tikka
Paula J. Agostini
Amy Kerr
Kerry Adams
Maninder S. Kalkat
Richard S. Steyn
Pala B. Rajesh
Ehab Bishay
David R. Thickett
Babu Naidu
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Journal of Cardiothoracic Surgery / Issue 1/2017
Electronic ISSN: 1749-8090
DOI: https://doi.org/10.1186/s13019-017-0614-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery

Abstract

Background

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2017

Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure –1 year results from the Ce mark trial

Surgical repair and reconstruction of aortic arch in debakey type I aortic dissection: recent advances and single-center experience in the application of branched stent graft

Left atrial thrombus due to transseptal catheterization simulating solid mass of right atrium

The correlation between the coaptation height of mitral valve and mitral regurgitation after mitral valve repair

Impact of prosthesis-patient mismatch after mitral valve replacement in rheumatic population: Does mitral position prosthesis-patient mismatch really exist?

Pulmonary inflammatory Myofibroblastic tumor indistinguishable from tuberculosis: a case report in a five-year-old child with hemoptysis